-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Silence Therapeutics plc quarterly/annual Operating Income (Loss) history and growth rate from Q1 2024 to Q2 2025.
- Silence Therapeutics plc Operating Income (Loss) for the quarter ending June 30, 2025 was -$24M, a 2.46% decline year-over-year.
- Silence Therapeutics plc annual Operating Income (Loss) for 2024 was -$63.3M, a 1.65% increase from 2023.
- Silence Therapeutics plc annual Operating Income (Loss) for 2023 was -$64.4M, a 5.48% decline from 2022.
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)